Navigating post-transplant relapse in acute myeloid leukemia: donor lymphocyte infusion, emerging cellular immunotherapies, and clinical management

Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the major obstacle to curing acute myeloid leukemia (AML). Even with modern advances, it continues to be the leading cause of treatment failure. The biology behind post-transplant relapse is multifaceted: leukemic cells evolve ways to evade immune detection, donor immune cells can become dysfunctional, the bone marrow microenvironment shifts in ways that favor leukemia, and the transplant itself reshapes immune dynamics in complex ways. This review brings these pieces together by combining mechanistic understanding with practical, evidence-based treatment pathways. The goal is to offer a clear framework for both preventing relapse and managing it when it occurs. We also highlight emerging strategies—such as biomarker-guided interventions, more precise immune modulation, microbiome-based approaches, and the integration of patient-reported outcomes—that aim to improve long-term disease control and overall survivorship. Current tools for risk assessment and immune monitoring are summarized, including measurable residual disease (MRD), donor chimerism, TIM-3 + leukemic stem cell tracking, leukemia-associated antigen-specific T-cell responses, and microbiome profiling. Together, these approaches help clinicians better anticipate relapse, tailor interventions, and refine post-transplant care.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-12
DOI
https://doi.org/10.3389/fimmu.2026.1896295
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Navigating post-transplant relapse in acute myeloid leukemia: donor lymphocyte infusion, emerging cellular immunotherapies, and clinical management

Pınar Ataca Atilla, Uğur Şahin, Erden Atilla
Frontiers in Immunology
Hematopoietic Stem Cell Transplantation
article

Navigating post-transplant relapse in acute myeloid leukemia: donor lymphocyte infusion, emerging cellular immunotherapies, and clinical management

Pınar Ataca Atilla, Uğur Şahin, Erden Atilla
article en

Abstract

Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the major obstacle to curing acute myeloid leukemia (AML). Even with modern advances, it continues to be the leading cause of treatment failure. The biology behind post-transplant relapse is multifaceted: leukemic cells evolve ways to evade immune detection, donor immune cells can become dysfunctional, the bone marrow microenvironment shifts in ways that favor leukemia, and the transplant itself reshapes immune dynamics in complex ways. This review brings these pieces together by combining mechanistic understanding with practical, evidence-based treatment pathways. The goal is to offer a clear framework for both preventing relapse and managing it when it occurs. We also highlight emerging strategies—such as biomarker-guided interventions, more precise immune modulation, microbiome-based approaches, and the integration of patient-reported outcomes—that aim to improve long-term disease control and overall survivorship. Current tools for risk assessment and immune monitoring are summarized, including measurable residual disease (MRD), donor chimerism, TIM-3 + leukemic stem cell tracking, leukemia-associated antigen-specific T-cell responses, and microbiome profiling. Together, these approaches help clinicians better anticipate relapse, tailor interventions, and refine post-transplant care.

Frontiers in ImmunologyVol. 17
University of Miami (US), Ankara University (TR), Sylvester Comprehensive Cancer Center (US)
Good health and well-being
Hematopoietic Stem Cell Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon